Earlier Melanoma Dx Seen in Regions With More Dermatologists
A study found that regions in the US with a higher density of dermatologists had lower rates of late-stage melanoma diagnoses from 2017 to 2021. The research analyzed data from 557 National Cancer Institute Health Service Areas and indicated that increased access to dermatologic care may lead to earlier detection of melanoma. The findings suggest that expanding the dermatology workforce in underserved areas could help reduce disparities in melanoma diagnosis stages.
- ▪Regions with more dermatologists had lower proportions of late-stage melanoma diagnoses.
- ▪The median dermatologist density was 1.97 per 100,000 population.
- ▪Higher educational attainment and insurance coverage were linked to lower odds of late-stage melanoma diagnosis.
Medscape files mainly under health. We currently carry 231 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Medscape |
| Canonical URL | https://www.medscape.com/viewarticle/higher-dermatologist-density-linked-lower-rates-late-stage-2026a1000gpc?src=rss |
| Publication time | Fri, 22 May 2026 07:54:13 EDT |
| Retrieval time | 2026-05-22T12:02:01.659Z |
| Last seen | 2026-05-22T12:02:01.659Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | sicnZdJ2cdDn |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
TOPLINE:Regions in the US with more dermatologists had lower proportions of late-stage melanoma diagnoses from 2017 to 2021 in a national ecological study.METHODOLOGY:A cross-sectional ecological study of 557 National Cancer Institute Health Service Areas (HSAs) analyzed data from the US Department of Health and Human Services State Cancer Profiles from 2017 to 2021.The median HSA demographics comprised 49.7% men, with 18.0% aged > 65 years; 79.8% were White, 6.3% Hispanic, and 4.9% Black individuals.Dermatologist density was categorized into five strata ranging from 0 to > 4 dermatologists per 100,000 population.The primary outcome was late-stage melanoma diagnosis, defined as regional or distant disease at the HSA level.TAKEAWAY:Overall, the median HSA dermatologist density was 1.97 per…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Medscape.
Discussion
0 commentsMore from Medscape
